Avid Bioservices Inc (CDMO)

[dia76ca]

Wonder how Bavi/Sorafenib would work in blood cancers when added to the SOC? Thorpe said that he thought Bavi would work in Leukemias if I remember correctly. The following is from 2014 ASH.

Leukemias

SORAML: Addition of Sorafenib to Standard Chemotherapy Induction and Consolidation Significantly Prolongs Event-Free and Relapse-Free Survival Compared With Placebo in Younger Patients With Newly Diagnosed AML
Sorafenib addition was associated with higher rates of some high-grade adverse events including infections, bleeding, and hand-foot syndrome.